Aviva
ADMA icon

Aviva’s ADMA Biologics ADMA Stock Holding History

Aviva’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$258K Buy
28,686
+1,685
+6% +$26.6K ﹤0.01% 836
2025
Q4 		$492K Sell
27,001
-2,612
-9% -$44K ﹤0.01% 770
2025
Q3 		$434K Buy
29,613
+5,492
+23% +$94.1K ﹤0.01% 839
2025
Q2 		$439K Sell
24,121
-11,385
-32% -$232K ﹤0.01% 837
2025
Q1 		$704K Buy
35,506
+4,079
+13% +$70.5K ﹤0.01% 641
2024
Q4 		$539K Buy
+31,427
New +$591K ﹤0.01% 807

Other funds holding ADMA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return